Market Overview

UPDATE: Federal Court Awards Enzo Biochem over $61M in Patent Infringement Damages Against Life Technologies

Related ENZ
Court Upholds $48.6M Jury Award to Enzo Biochem
Enzo Biochem, Inc. Enters into $8.0M Senior Secured Revolving Credit Facility with Healthcare Finance Group

Enzo Biochem Inc. (NYSE: ENZ) reported today that a Federal Court Judge
in New Haven, CT, in connection with the favorable November 2012 jury
finding of direct infringement damages of Enzo patents by Applera Corp.,
now Life Technologies Inc. (NASDAQ: LIFE), has awarded the Company
prejudgment interest of $12,428,729, bringing the total award to in
excess of $61 million. Additional post-interest on the full amount was
also awarded starting November 7, 2012 until the total judgment is
satisfied, which, it is estimated, could add several additional millions.

See full press release

Posted-In: News Guidance Management Global


Most Popular

Related Articles (LIFE + ENZ)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free